Rigel Pharmaceuticals (RIGL)
Add to Watchlists Create an Alert
4.52
-0.06 -1.31%
NASDAQ
May 22, 4:59PM
BATS Real time
Currency in USD
Rigel Pharmaceuticals Net Income Quarterly:
-25.47M for Dec. 31, 2012Rigel Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -25.47M |
| Sept. 30, 2012 | -25.46M |
| June 30, 2012 | -24.74M |
| March 31, 2012 | -23.17M |
| Dec. 31, 2011 | -25.79M |
| Sept. 30, 2011 | -17.93M |
| June 30, 2011 | -21.47M |
| March 31, 2011 | -20.78M |
| Dec. 31, 2010 | -17.24M |
| Sept. 30, 2010 | 50.43M |
| June 30, 2010 | 27.03M |
| March 31, 2010 | -22.33M |
| Dec. 31, 2009 | -25.09M |
| Sept. 30, 2009 | -26.65M |
| June 30, 2009 | -29.88M |
| March 31, 2009 | -29.92M |
| Dec. 31, 2008 | -33.36M |
| Sept. 30, 2008 | -37.69M |
| June 30, 2008 | -34.03M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
| Sept. 30, 2000 | Go Pro |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
RIGL Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| AstraZeneca | 1.011B |
| MEI Pharma | -2.754M |
| Lannett Company | 2.881M |
RIGL Net Income Quarterly Rankings
| Overall |
34th percentile 5276 of 8005 |
| Sector |
10th percentile 614 of 686 in Healthcare |
| Industry |
11th percentile 60 of 68 in Drug Manufacturers - Specialty & Generic |
RIGL Net Income Quarterly Range, Past 5 Years
| Minimum | -37.69M | Sep 2008 |
| Maximum | 50.43M | Sep 2010 |
| Average | -19.13M |
